Prediction of Bone Metastasis in Prostate Cancer Using Blood Glucose-6-Phosphate Dehydrogenase Activity: A Retrospective Medical Record Review
Chang-Hwan Yeom, Jiewon Lee, Keun-Joo Bae, Kangseok Kim, Jongsoon Choi, Myeong-Hun Lim · 2025
Read Prediction of Bone Metastasis in Prostate Cancer Using Blood Glucose-6-Phosphate Dehydrogenase Activity: A Retrospective Medical Record Review by Chang-Hwan Yeom, Jiewon Lee, Keun-Joo Bae, Kangseok Kim, Jongsoon Choi, Myeong-Hun Lim (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12784825.txt.
Description
Chang-Hwan Yeom and five co-authors test a blood enzyme as a warning sign for prostate cancer spread in a 2025 record review. Bone is the most common site this cancer spreads to, and knowing the risk early shapes treatment choices. The enzyme, called G6PD, helps cells handle energy and stress.
The team compared enzyme activity in 56 patients with and without bone spread. Activity ran much higher in those whose cancer had reached bone. A standard accuracy test rated the marker fairly good, and the authors set a cutoff value that caught most cases while clearing most others. They present the enzyme level as a simple, non-invasive extra tool for judging spread risk.
Catalog record
| CREATOR | Chang-Hwan Yeom, Jiewon Lee, Keun-Joo Bae, Kangseok Kim, Jongsoon Choi, Myeong-Hun Lim |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 21 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |